Asahi Enterprise to ratify name change certificate at EGM on Oct 30

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • EGM scheduled for October 30, 2026, to ratify CA certificate for name change
  • Name changed from Global Longlife Hospital to Asahi Enterprise Limited
  • Investment in new activity of ₹1,702.15 lakh exceeds 50% of total assets
  • Total assets stood at ₹2,372.98 lakh as of June 30, 2026
powered bylight_fuzz_icon
52917998

*this image is generated using AI for illustrative purposes only.

Asahi Enterprise Limited , formerly known as Global Longlife Hospital and Research Limited, has scheduled an Extra Ordinary General Meeting (EGM) for Friday, October 30, 2026. The meeting aims to ratify the submission of a Practicing Chartered Accountant’s certificate required under Regulation 45 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, in connection with the company’s recent name change.

The EGM will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM) at 12:15 pm IST. The primary agenda item involves a Special Resolution to approve the acts done by the Board of Directors in obtaining and submitting the CA certificate confirming compliance with regulatory conditions for changing the company’s name from Global Longlife Hospital and Research Limited to Asahi Enterprise Limited.

Background of the Name Change

The shareholders had previously approved the name change at the Annual General Meeting held on June 25, 2026. However, the specific CA certificate mandated by BSE Limited and SEBI regulations was inadvertently omitted from the explanatory statement of that AGM notice. Consequently, the company received in-principle approval from BSE Limited on August 27, 2026, and the Registrar of Companies issued the Certificate of Incorporation for the new name on September 25, 2026. This EGM seeks to retrospectively ratify the submission of the missing certificate to ensure full regulatory compliance.

Financial Compliance Details

To satisfy Regulation 45(1)(c), which requires that the amount invested in the new activity is at least fifty percent of the assets of the listed entity, the company provided a detailed breakdown of its financial position as of June 30, 2026. The certificate issued by M/s MSNJ & Associates confirmed that the investment in the new activity exceeded the threshold.

Particulars Amount (₹ lakh)
Total Assets 2,372.98
50% of Total Assets 1,186.49
Investment in New Activity 1,702.15

The components of assets included Cash and Cash Equivalents of ₹1,702.15 lakh, which constituted 71.73% of total assets. Other current assets totaled ₹2,261.92 lakh, while preliminary expenses stood at ₹111.07 lakh.

What the Numbers Show

The compliance with Regulation 45(1)(c) relies heavily on the composition of the company's current assets. With Cash and Cash Equivalents accounting for ₹1,702.15 lakh out of total assets of ₹2,372.98 lakh, cash holdings represent over 71% of the balance sheet. This high liquidity position allows the company to meet the requirement that investments in the new activity exceed 50% of total assets, despite the lack of significant tangible fixed assets or long-term investments disclosed in the immediate asset breakdown.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
+4.87%-8.50%0.0%-15.67%0.0%-90.93%

What specific new business activities will Asahi Enterprise Limited pursue to deploy the ₹1,702.15 lakh in cash reserves, given the pivot from a hospital and research focus?

How will the retrospective ratification of the CA certificate impact the company's standing with SEBI regarding future compliance audits and potential regulatory scrutiny?

Does the high proportion of cash assets (71.73%) suggest a potential acquisition strategy or a shift toward a holding company model rather than operational healthcare services?

Global Longlife Hospital & Research
View Company Insights
View All News
like15
dislike

Abhishek Kamdar HUF buys 5.09% stake in Global Longlife Hospital

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Abhishek Ashvinbhaj Kamdar HUF acquired 5,35,000 shares in Global Longlife Hospital and Research Ltd
  • The stake represents 5.09% of total voting capital, crossing the mandatory disclosure threshold
  • Acquisition occurred via open market on September 25, 2026, with no prior holdings recorded
  • Total share capital remains unchanged at 1,05,00,000 equity shares of ₹10 face value each
powered bylight_fuzz_icon
51952068

*this image is generated using AI for illustrative purposes only.

Global Longlife Hospital and Research Ltd saw a significant shift in its shareholding pattern following an open market acquisition by Abhishek Ashvinbhaj Kamdar HUF. The Hindu Undivided Family (HUF) acquired 5,35,000 equity shares, representing 5.09% of the company’s total voting capital, on September 25, 2026.

This transaction marks the initial holding for the acquirer, as the disclosure indicates a nil position prior to this acquisition. The purchase was executed through the open market segment on the BSE, where the hospital chain’s shares are listed. The acquirer is not part of the promoter or promoter group, classifying this as a substantial acquisition by a non-promoter entity under SEBI regulations.

Acquisition Details

The filing confirms that the total share capital of the target company remained unchanged at 1,05,00,000 equity shares with a face value of ₹10 each, aggregating to ₹10,50,00,000. The diluted share capital also remains identical to the paid-up equity capital, indicating no outstanding convertible instruments that would alter the denominator for percentage calculations.

Metric Details
Acquirer Abhishek Ashvinbhaj Kamdar HUF
Shares Acquired 5,35,000
Percentage Holding 5.09%
Mode of Acquisition Open Market
Date of Acquisition September 25, 2026
Pre-acquisition Holding Nil
Post-acquisition Holding 5.09%

Regulatory Disclosure

The acquisition triggers disclosures under Regulation 29(1) and Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The threshold for mandatory disclosure was crossed as the holding moved from zero to above 5%. The Karta of the HUF, Abhishek Ashvinbhai Kamdar, signed the declaration from Surat, Gujarat.

What the Numbers Show

The data reveals a clean entry into the shareholder base. Since the pre-acquisition holding was nil, the entire 5.09% stake represents new money entering the register. The absence of encumbrances, warrants, or convertible securities in the post-acquisition column suggests the HUF holds pure equity voting rights without any derivative exposure or pledged collateral associated with these specific shares. This concentration of ownership in a single non-promoter entity could influence future voting dynamics given the relatively small total share count of 1.05 crore.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
+4.87%-8.50%0.0%-15.67%0.0%-90.93%

Will the Abhishek Ashvinbhaj Kamdar HUF increase its stake beyond the 5% threshold, potentially triggering further regulatory disclosures or takeover implications?

How might this new 5.09% non-promoter block influence voting dynamics on upcoming board resolutions given the company's small total share count?

Is there any indication of strategic alignment between the acquirer and Global Longlife Hospital’s management regarding future expansion or operational changes?

Global Longlife Hospital & Research
View Company Insights
View All News
like15
dislike

More News on Global Longlife Hospital & Research

1 Year Returns:0.00%